Related Experiment Videos
Acute dystonic reaction to bethanechol--a direct acetylcholine receptor agonist
Insights
Bethanechol, an acetylcholine receptor agonist, caused acute dystonic reactions in an infant. This finding supports theories linking acetylcholine and dopamine to dystonic reactions.
Area of Science:
- Pharmacology
- Neurology
- Pediatrics
Background:
- Bethanechol, a direct acetylcholine receptor agonist, is a new treatment for gastroesophageal reflux.
- Acute dystonic reactions are involuntary muscle contractions often associated with dopamine receptor antagonism.
Observation:
- A 10-month-old infant experienced acute dystonic reactions after receiving bethanechol.
- The infant had previously shown similar reactions to two different classes of dopamine receptor blocking agents.
Findings:
- This is the first reported case of acute dystonic reactions to a cholinergic agonist in humans.
- The infant's reactions to both bethanechol and dopamine antagonists suggest a complex interplay between acetylcholine and dopamine in dystonia.
Implications:
- These findings align with current theories on the roles of acetylcholine and dopamine in the development of acute dystonic reactions.
- Further research is warranted to understand the neurochemical mechanisms underlying bethanechol-induced dystonia and its relationship with dopamine pathways.
Abstract:
Bethanechol is a direct agonist of the acetylcholine receptor that was recently introduced in the therapy of gastro-oesophageal reflux. Acute dystonic reactions to bethanechol were observed in a 10-month-old infant who also demonstrated similar dystonic reactions to dopamine receptor blocking agents of two different classes. This first report of acute dystonic reaction to cholinergic agonists in human is in accord with the current theories of the rôle of acetylcholine and dopamine in the pathogenesis of acute dystonic reactions.